← All stocks

Larimar Therapeutics, Inc.

LRMR No buying or selling

CIK 0001374690 #3232 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

8 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Flynn James E

Director

—

6,207,982

$20.72M

—

Hamilton Thomas Edward

Director

—

714,798

$2.39M

+26.6%

BEN-MAIMON CAROLE

President and CEO

—

368,276

$1.23M

+107.9%

Celano Michael

Chief Financial Officer

—

215,785

$720.25K

+49.9%

Shankar Gopi

Chief Development Officer

—

76,443

$255.15K

+178.0%

Clayton Russell

Chief Medical Officer

—

71,443

$238.46K

+217.5%

THOMAS FRANK E

Director

—

7,000

$23.36K

+250.0%

SHERMAN JEFFREY W

Director

—

5,000

$16.69K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 31 Aug 2016